Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 375

1.

Tubular carcinoma of the breast: an institutional experience and review of the literature.

Cabral AH, Recine M, Paramo JC, McPhee MM, Poppiti R, Mesko TW.

Breast J. 2003 Jul-Aug;9(4):298-301. Review.

PMID:
12846864
2.

Optimal management of ductal carcinoma in situ of the breast.

Sakorafas GH, Farley DR.

Surg Oncol. 2003 Dec;12(4):221-40. Review.

PMID:
14998563
3.

Tubular carcinoma of the breast. Predicting axillary nodal metastases and recurrence.

Winchester DJ, Sahin AA, Tucker SL, Singletary SE.

Ann Surg. 1996 Mar;223(3):342-7. Review.

4.

Tubular carcinoma of the breast: a population-based study of nodal metastases at presentation and of patterns of relapse.

Kader HA, Jackson J, Mates D, Andersen S, Hayes M, Olivotto IA.

Breast J. 2001 Jan-Feb;7(1):8-13.

PMID:
11348409
5.

Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.

Padmore RF, Fowble B, Hoffman J, Rosser C, Hanlon A, Patchefsky AS.

Cancer. 2000 Mar 15;88(6):1403-9.

PMID:
10717623
6.
7.

Treatment for ductal carcinoma in situ in an Asian population: outcome and prognostic factors.

Chuwa EW, Tan VH, Tan PH, Yong WS, Ho GH, Wong CY.

ANZ J Surg. 2008 Jan-Feb;78(1-2):42-8. doi: 10.1111/j.1445-2197.2007.04354.x.

PMID:
18199204
8.

A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.

Di Saverio S, Gutierrez J, Avisar E.

Breast Cancer Res Treat. 2008 Oct;111(3):541-7. Epub 2007 Nov 18.

PMID:
18026874
9.

Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.

Caliskan M, Gatti G, Sosnovskikh I, Rotmensz N, Botteri E, Musmeci S, Rosali dos Santos G, Viale G, Luini A.

Breast Cancer Res Treat. 2008 Dec;112(3):513-21. doi: 10.1007/s10549-007-9880-5. Epub 2008 Feb 1.

PMID:
18240020
10.

Determinants of prognosis in breast cancer patients with tumor involvement of the skin (pT4b).

Wieland AW, Louwman MW, Voogd AC, van Beek MW, Vreugdenhil G, Roumen RM.

Breast J. 2004 Mar-Apr;10(2):123-8.

PMID:
15009039
11.

Factors predicting in-breast tumor recurrence after breast-conserving surgery.

Mechera R, Viehl CT, Oertli D.

Breast Cancer Res Treat. 2009 Jul;116(1):171-7. doi: 10.1007/s10549-008-0187-y. Epub 2008 Sep 25.

PMID:
18815880
12.

259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.

Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.

Breast Cancer Res Treat. 2008 Jun;109(3):405-16. Epub 2007 Aug 9. Review.

PMID:
17687650
13.

Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.

Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR.

Jpn J Clin Oncol. 2005 Mar;35(3):126-33.

PMID:
15741302
14.

Conservation therapy for breast cancers other than infiltrating ductal carcinoma.

Kurtz JM, Jacquemier J, Torhorst J, Spitalier JM, Amalric R, H√ľnig R, Walther E, Harder F, Almendral A, Brandone H, et al.

Cancer. 1989 Apr 15;63(8):1630-5.

PMID:
2538219
15.

Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.

Cabioglu N, Krishnamurthy S, Kuerer HM, Hunt KK, Singletary SE, Meric-Bernstam F, Ross MI, Feig BW, Ames FC, Babiera GV.

Cancer. 2004 Aug 1;101(3):508-17.

16.

Breast carcinoma in women age 25 years or less.

Kothari AS, Beechey-Newman N, D'Arrigo C, Hanby AM, Ryder K, Hamed H, Fentiman IS.

Cancer. 2002 Feb 1;94(3):606-14.

17.

Tubular carcinoma of the breast: a retrospective analysis and review of the literature.

Sullivan T, Raad RA, Goldberg S, Assaad SI, Gadd M, Smith BL, Powell SN, Taghian AG.

Breast Cancer Res Treat. 2005 Oct;93(3):199-205. Review.

PMID:
16142444
18.

Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.

Mazouni C, Peintinger F, Wan-Kau S, Andre F, Gonzalez-Angulo AM, Symmans WF, Meric-Bernstam F, Valero V, Hortobagyi GN, Pusztai L.

J Clin Oncol. 2007 Jul 1;25(19):2650-5.

PMID:
17602071
19.

Axillary recurrence in DCIs: is axillary lymphadenectomy warranted?

Trisal V, Qian D, Wagman LD.

Am Surg. 2004 Oct;70(10):876-80.

PMID:
15529841
20.

Supplemental Content

Support Center